Author | Rachel Lutz


Report Describes Use of Ruxolitinib Over the Long-Term for Young Patient

August 29, 2020

Researchers discuss the case of a 32-year-old patient who is being treated with ruxolitinib over a period of years to treat steroid refractory graft-versus-host disease.

Understanding Clinical Considerations for Patients With Both COPD, Cardiovascular Disease

July 18, 2020

A recent review discussed how to manage comorbid cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).

Researchers Explore Benefits of Using Composite End Points in COPD Trials

July 17, 2020

Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.

Does Diet Have an Effect on COPD Prevalence and Incidence?

July 11, 2020

The focus on curbing COPD prevalence has largely focused on smoking cessation, but there are other factors, including diet, that can contribute to the risk of developing COPD.